A2 Milk's push into China bolstered by results of human clinical trial in that country

Fiona Rotherham
Tue, 19 Apr 2016

By Fiona Rotherham April 19 (BusinessDesk) - Specialty milk marketer A2 Milk has bolstered its push to sell more products in China through a recently completed human clinical trial comparing the gastrointestinal and cognitive effects of consuming milk containing the A1 beta casein with that of the A2 variant on people with self-reported lactose intolerance. The results of the Chinese study were published this month in the Nutrition Journal and are due to be released at a Beijing press conference late tomorrow by the company. It’s part...
Opinion
PATTRICK SMELLIE: What do the Nats do now?
Pattrick Smellie | Tue, 14 Jul 2020

Todd Muller's only job as National Party leader was to lose the election better than it seemed Simon Bridges was destined to do. Whoever replaces Muller has an even simpler task: save as much of th...

Listed Companies
Huljich family sells 25% of Pushpay stake
Dan Brunskill | Tue, 14 Jul 2020

The Huljich family has sold a quarter of its cornerstone stake in Pushpay Holdings, one of the rising software company stars. The 14.4 million shares were sold for $123.8 million, or $8.60 per shar...

Property
Housing market rebounds sharply; caution required
Jenny Ruth | Tue, 14 Jul 2020

The housing market bounded out of lockdown last month with sales volumes the highest for June in four years and prices nationally up 8.6 percent from a year earlier. The Real Estate Institute's lat...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.